Isopropylamine

Isopropylamine

SCHEMBL3156399

CC(C)C(C)C.CC(C)N

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
TSHR P16473 2/20 0.62
HSD17B10 Q99714 1/20 0.62
SLC7A5 Q01650 1/20 0.35
MAPK1 P28482 1/20 0.33
LAP3 P28838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropylamine SCHEMBL3957156 0.94 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10SLC7A5MAPK1
Isopropylamine SCHEMBL30440281 0.87
Isopropylamine SCHEMBL19813885 0.87
Isopropylamine SCHEMBL2909 0.87
Isopropylamine SCHEMBL8103474 0.82 ALDH1A1 (0.40) ALDH1A1TSHRHSD17B10SLC7A5MAPK1
Isopropylamine SCHEMBL635472 0.80
Isopropylamine SCHEMBL438025 0.80
Isopropylamine SCHEMBL10740624 0.80
Isopropylamine SCHEMBL20769333 0.80
Isopropylamine SCHEMBL7198176 0.80 ALDH1A1 (0.42) ALDH1A1TSHRHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386908-B1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE INST PHARM & TOXICOLOGY AMMS (CN) 2010-03-03 EP claimed
CN-101502502-A Medicament composition for preventing and treating ischemia-reperfusion injury of kidney BEIJING ENHUA PHARMACEUTICAL I (CN) 2009-08-12 CN claimed
CN-1250518-C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN claimed
CN-1250519-C Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN claimed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN claimed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 US claimed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 EP claimed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN claimed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN claimed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN claimed
EP-1386908-B1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE INST PHARM & TOXICOLOGY AMMS (CN) 2010-03-03 EP disclosed
US-7560473-B2 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES, P.L.A. (CN) 2009-07-14 US disclosed
CN-1250518-C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
CN-1250519-C Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN disclosed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 US disclosed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 EP disclosed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN disclosed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN disclosed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use KCNMA1, KCNA5, KCNA1 ALDH1A1 428/4885TSHR 2809/4885HSD17B10 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.